• Study of belumosudil in children aged 1 to 18 years with moderate to severe chronic graft versus host disease requiring systemic treatment

    Recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Italy The Netherlands Spain
  • Study of dostarlimab treatment before surgery in patients with stage II-III endometrial cancer with specific genetic markers

    Recruiting

    2 1 1 1
    Investigated Drugs:
    Spain
  • Study of drug combination therapy after surgery in patients with resectable pancreatic ductal adenocarcinoma using lab-grown mini-tumors to guide treatment selection

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Germany
  • Study of Tarlatamab and Temozolomide combination treatment in adolescents and adults with high grade brain tumors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study of Faricimab treatment to improve vision in patients with diabetic macular edema using adaptive optics imaging

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Study of loncastuximab tesirine and epcoritamab combination treatment for patients with relapsed or refractory diffuse large B-cell lymphoma

    Recruiting

    2 1 1 1
    Germany
  • Study comparing tadalafil with ambrisentan versus tadalafil alone in newly diagnosed patients with pulmonary arterial hypertension who have cardiovascular conditions

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study of encorafenib and cetuximab treatment for patients with BRAF V600E-mutant metastatic colorectal cancer who previously responded to BRAF inhibitor therapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Study of pembrolizumab and lenvatinib treatment for patients with vulvar cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    Italy
  • Study comparing remibrutinib and ocrelizumab in patients with relapsing multiple sclerosis who switch from ocrelizumab treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia Denmark France Germany Greece +4

powered by